To substitute or not? A systematic review of immunoglobulin replacement therapy in multiple myeloma patients treated with bispecific antibodies.

Paulsen JS, Slørdahl TS

Open source

DOI
10.3389/fimmu.2025.1722579
Published
2025
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1722579,
  title = {To substitute or not? A systematic review of immunoglobulin replacement therapy in multiple myeloma patients treated with bispecific antibodies.},
  author = {Paulsen JS and Slørdahl TS},
  year = {2025},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2025.1722579},
  url = {https://doi.org/10.3389/fimmu.2025.1722579}
}

RIS

TY  - JOUR
TI  - To substitute or not? A systematic review of immunoglobulin replacement therapy in multiple myeloma patients treated with bispecific antibodies.
AU  - Paulsen JS
AU  - Slørdahl TS
PY  - 2025
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2025.1722579
UR  - https://doi.org/10.3389/fimmu.2025.1722579
ER  - 

APA

JS, P., & TS, S. (2025). To substitute or not? A systematic review of immunoglobulin replacement therapy in multiple myeloma patients treated with bispecific antibodies.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1722579

Source records